Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 10, 2006, Pages 4638-4645

  Van Eeden, Pauline E ^a   Tee, Lisa B G ^a   Lukehurst, Sherralee ^a   Lai, Chooi May ^b   Rakoczy, Elizabeth P ^b   Beazley, Lyn D ^a,c   Dunlop, Sarah A ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RHODOPSIN; VASCULOTROPIN; MESSENGER RNA; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETIC RETINOPATHY; FLUORESCENCE MICROSCOPY; GRIFFONIA; MICROSCOPY; MOUSE; NERVE FIBER; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA GANGLION CELL; RETINA NEOVASCULARIZATION; TISSUE SECTION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; CAPILLARY PERMEABILITY; DISEASE MODEL; ENZYME IMMUNOASSAY; FLUORESCENCE ANGIOGRAPHY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOLOGY; PRENATAL DEVELOPMENT; RETINA; RETINA BLOOD VESSEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; CAPILLARY PERMEABILITY; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; FLUORESCEIN ANGIOGRAPHY; IMMUNOENZYME TECHNIQUES; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; NERVE FIBERS; RETINA; RETINAL GANGLION CELLS; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHODOPSIN; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33750603120     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0251     Document Type: Article

References (57)

1. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care. 1998;21:143-156.
2. Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27:2540-2553.
3. Campochiaro PA. Retinal and choroidal neovascularization. J Cell Physiol. 2000;184:301-310.
4. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SH, Adamis AP. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol. 2001;158:147-152.
5. Miyamoto K, Khosrof S, Bursell SE, et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol. 2000;156:1733-1739.
6. Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48-58.
7. Tolentino MJ, McLeod DS, Taomoto M, Otsuji T, Adamis AP, Lutty GA. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am J Ophthalmol. 2002;133:373-385.
8. Winkler BS, Arnold MJ, Brassell MA, Puro DG. Energy metabolism in human retinal Müller cells. Invest Ophthalmol Vis Sci. 2000;41:3183-3190.
9. Lieth E, Gardner TW, Barber AJ, Antonetti DA. Retinal neurodegeneration: early pathology in diabetes. Clin Exp Ophthalmol. 2000;28:3-8.
10. Fletcher EL, Phipps JA, Wilkinson-Berka JL. Dysfunction of retinal neurons and glia during diabetes. Clin Exp Optom. 2005;88:132-145.
11. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest. 1998;102:783-791.
12. Feit-Leichnam R, Kinouchi R, Takeda M, et al. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci. 2005;46:4281-4287.
13. Rossini AA, Appel MC, Williams RM, Like AA. Genetic influence of the streptozotocin-induced insulitis and hyperglycemia. Diabetes. 1977;26:916-920.
14. Wick MM, Rossini A, Glynn D. Reduction of streptozotocin toxicity by 3-O-methyl-D-glucose with enhancement of antitumor activity in murine L1210 leukemia. Cancer Res. 1977;37:3901-3903.
15. Barber AJ, Antonetti DA, Kern TS, et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci. 2005;46:2210-2218.
16. Ruberte J, Ayuso E, Navarro M, et al. Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. J Clin Invest. 2004;113:1149-1157.
17. Okamoto N, Tobe T, Hackett SF, et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol. 1997;151:281-291.
18. Tobe T, Okamoto N, Vinores MA, et al. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci. 1998;39:180-188.
19. Lai CM, Dunlop SA, May LA, et al. Generation of transgenic mice with mild and severe retinal neovascularisation. Br J Ophthalmol. 2005;89:911-916.
20. Shen WY, Lai M-L, Graham CE, et al. Long-term global retinal microvascular changes in a transgenic VEGF mouse model. Diabetologia. 2006;49:1690-1701.
21. Ohno-Matsui K, Hirose A, Yamamoto S, et al. Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol. 2002;160:711-719.
22. van Eeden PE, Tee LBG, Lai CM, et al. Characterisation of a VEGF transgenic mouse model for retinal neovascularization (abstract). Proc Aust Neurosci Soc. 2005;14:P40.
23. Shen WY, Lai CM, Graham CE, et al. Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model. Diabetologia. 2006;49:1690-1701.
24. Harman AM, Sanderson KJ, Beazley LD. Biphasic retinal neurogenesis in the brush-tailed possum. Trichosurus vulpecula: further evidence for the mechanisms involved in formation of ganglion cell density gradients. J Comp Neurol. 1992;325:595-606.
25. Moore J, Bagley S, Ireland G, McLeod D, Boulton ME. Three dimensional analysis of microaneurysms in the human diabetic retina. J Anat. 1999;19-í:89-100.
26. Bek T. Transretinal histopathological changes in capillary-free areas of diabetic retinopathy. Acta Ophthalmol (Copenh). 1994;72:409-415.
27. Tee LBG, O'Shea JE, Cheong T, et al. Choroidal damage in VEGF transgenic mice correlates with severity of retinopathy (abstract). Proc Aust Neurosci Soc. 2006;26:P06.
28. Fryczkowski AW, Hodes BL, Walker J. Diabetic choroidal and iris vasculature scanning electron microscopy findings. Int Ophthalmol. 1989;13:269-279.
29. McLeod DS, Lutty GA. High-resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol Vis Sci. 1994;35:3799-3811.
30. Morrow EM, Belliveau MJ, Cepko CL. Two phases of rod photoreceptor differentiation during rat retinal development. J Neurosci. 1998;18:3738-3748.
31. Young RW. Cell proliferation during postnatal development of the retina in the mouse. Brain Res. 1985;353:229-239.
32. Blanks JC, Bok D. An autoradiographic analysis of postnatal cell proliferation in the normal and degenerative mouse retina. J Comp Neurol. 1977;174:317-327.
33. Engerman RL, Meyer RK. Development of retinal vasculature in rats. Am J Ophthalmol. 1965;60:628-641.
34. Henkind P, Bellhorn RW, Murphy ME, Roa N. Development of macular vessels in monkey and cat. Br J Ophthalmol. 1975;59:703-709-
35. Provis JM, Diaz CM, Dreher B. Ontogeny of the primate fovea: a central issue in retinal development. Prog Neurobiol. 1998;54:549-580.
36. Provis JM, Leech J, Diaz CM, Penfold PL, Stone J, Keshet E. Development of the human retinal vasculature: cellular relations and VEGF expression. Exp Eye Res. 1997;65:555-568.
37. Chan-Ling TL, Halasz P, Stone J. Development of retinal vasculature in the cat: processes and mechanisms. Curr Eye Res. 1990;9:459-478.
38. Chan-Ling T, Tout S, Hollander H, Stone J. Vascular changes and their mechanisms in the feline model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1992;33:2128-2147.
39. Feman SS, Leonard-Martin TC, Semchyshyn TM. The topographic distribution of the first situs of diabetic retinal neovascularization. Am J Ophthalmol. 1998;123:704-706.
40. Diabetic Retinopathy Study Group. Diabetic retinopathy study. Report number 6. Design, methods, and baseline results. Report number 7. A modification of the Airlic House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci. 1981;21:1-226.
41. Early Treatment Diabetic Retinopathy Study Research Group. Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Ophthalmology. 1991;98:834-840.
42. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlic House classification. ETDRS report number 10. Ophthalmology. 1991;98:786-806.
43. Stitt AW, Gardiner TA, Archer DB. Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. Br J Ophthalmol. 1995;79:362-367.
44. Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450-1452.
45. Joussen AM, Poulaki V, Qin W, et al. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol. 2002;160:501-509.
46. Wolter JR. Diabetic retinopathy. Am J Ophthalmol. 1961;51:1123-1141.
47. Bloodworth JM Jr. Diabetic retinopathy. Diabetes. 1962;11:1-22.
48. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:283-290.
49. Alder VA, Su EN, Yu DY, Cringle SJ, Yu PK. Diabetic retinopathy: early functional changes. Clin Exp Pharmacol Physiol. 1997;24:785-788.
50. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci. 2004;45:3330-3336.
51. Juen S, Kieselbach GF. Electrophysiological changes in juvenile diabetics without retinopathy. Arch Ophthalmol. 1990;108:372-375.
52. Simonsen SE. The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol (Copenh). 1980;58:865-878.
53. Aizu Y, Oyanagi K, Hu J, Nakagawa H. Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin- diabetic rats. Neuropathology. 2002;22:161-170.
54. Park SH, Park JW, Park SJ, et al. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia. 2003;46:1260-1268.
55. Hancock HA, Kraft TW. Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci. 2004;45:1002-1008.
56. Bek T. Immunohistochemical characterization of retinal glial cell changes in areas of vascular occlusion secondary to diabetic retinopathy. Acta Ophthalmol Scand 1997;75:388-392.
57. Bek T. Glial cell involvement in vascular occlusion of diabetic retinopathy. Acta Ophthalmol Scand. 1997;75:239-243.